First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-07-21 06:37:48Open Document File Size: 988,77 KBShare Result on FacebookCompanyEli Lilly and Company / Wellcome Trust / Twitter / UCB Pharma / /CountryEstonia / United Kingdom / /EventPerson Communication and Meetings / /FacilityNeil Weir / /IndustryTermdivergent / healthcare / pharmaceutical / case law / withdrawn products / healthcare priorities / unsuccessful applications / elegant solution / healthcare spectrum / /MedicalConditionrare diseases / disease / HIV/ AIDS / diseases / metabolic disease / /OrganizationEuropean Union Agency / EFPIA's Scientific / Regulatory and Manufacturing Policy Committee / London School of Hygiene and Tropical Medicine / office of the European Ombudsman / Draft Agency / European Medicines Agency / Eichler / Vice / Nordic Cochrane Centre / European Union / An / European Rare Disease Organisation / /PersonBen Goldacre / Mark Walport / Peter Gøtzsche / Guido Rasi / Susan Forda / Buttarelli / Virginia Barbour / François Houÿez / Nada Photography / Hans-Georg Eichler / /PositionPresident of Discovery / Executive Director / healthcare commentator in the UK / Supervisor and a representative / Health Policy officer / Senior Medical Officer / President / International Regulatory Affairs / Data Protection Supervisor / Supervisor / Director / way forward / data and transparency Workshop report Director / Chief Editor / Chair / representative / Assistant / judge / /PublishedMediumPLoS Medicine / /URLwww.ema.europa.eu / /SocialTag |